Critics argue that the primary mission of a health insurance fund is to provide medical care, not to act as a speculative investment firm. The loss of 170 million euros is viewed as an unacceptable gamble with money that belongs to the public. When these funds engage in complex financial markets, they expose themselves to risks that can directly impact the financial security of the entire healthcare system and, by extension, the contributors who pay for it.
There is a growing concern that the pursuit of higher returns has led some funds to move away from low-risk, stable assets toward more volatile financial products. This shift is seen as a departure from the core responsibility of these institutions, which is to act as safe stewards of public money. Critics point out that when these investments fail, it is the insured members who ultimately pay the price, either through higher contribution rates or reduced services, while the funds themselves face little direct accountability for their poor decision-making.
Transparency is another major issue. Many members are unaware that their contributions are being used in financial markets, and there is often a lack of clear reporting on the specific risks associated with these portfolios. This lack of visibility makes it difficult for the public to hold fund managers accountable for their performance. There is a strong call for more stringent oversight, including mandatory limits on the types of assets that can be purchased and more frequent audits by independent financial regulators.
Ultimately, the argument is that the safety of the healthcare system should never be compromised by financial speculation. Critics advocate for a more conservative approach that prioritizes capital preservation over profit generation. By limiting the investment scope of these funds, the government could ensure that the money intended for doctors, hospitals, and medicine remains secure, regardless of the ups and downs of the global financial markets.